[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

Asia-Pacific Therapeutic Nuclear Medicines Market Report 2018

June 2018 | 106 pages | ID: A5A1AD1E607EN
QYResearch

US$ 4,000.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the Asia-Pacific Therapeutic Nuclear Medicines market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report split Asia-Pacific into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Therapeutic Nuclear Medicines for these regions, from 2013 to 2025 (forecast), including
  • China
  • Japan
  • South Korea
  • Taiwan
  • India
  • Southeast Asia
  • Australia
Asia-Pacific Therapeutic Nuclear Medicines market competition by top manufacturers/players, with Therapeutic Nuclear Medicines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Cardinal Health
  • Mallinckrodt
  • GE Healthcare
  • Lantheus Medical Imaging
  • Bayer
  • Bracco Imaging
  • Eczacibasi-Monrol Nuclear Products
  • Nordion
  • Advanced Accelerator Applications
  • IBA Molecular Imaging
On the basis of product, this report displays the sales volum, revenue, product price, market share and growth rate of each type, primarily split into
  • Beta Emitters
  • Alpha Emitters
  • Brachytherapy Products
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Thyroid
  • Bone Metastasis
  • Lymphoma
  • Endocrine Tumors
  • Others
Asia-Pacific Therapeutic Nuclear Medicines Market Report 2018

1 THERAPEUTIC NUCLEAR MEDICINES OVERVIEW

1.1 Product Overview and Scope of Therapeutic Nuclear Medicines
1.2 Classification of Therapeutic Nuclear Medicines by Product Category
  1.2.1 Asia-Pacific Therapeutic Nuclear Medicines Market Size (Sales) Comparison by Types (2013-2025)
  1.2.2 Asia-Pacific Therapeutic Nuclear Medicines Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 Beta Emitters
  1.2.4 Alpha Emitters
  1.2.5 Brachytherapy Products
1.3 Asia-Pacific Therapeutic Nuclear Medicines Market by Application/End Users
  1.3.1 Asia-Pacific Therapeutic Nuclear Medicines Sales (Volume) and Market Share Comparison by Applications (2013-2025)
  1.3.2 Thyroid
  1.3.3 Bone Metastasis
  1.3.4 Lymphoma
  1.3.5 Endocrine Tumors
  1.3.6 Others
1.4 Asia-Pacific Therapeutic Nuclear Medicines Market by Region
  1.4.1 Asia-Pacific Therapeutic Nuclear Medicines Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 China Status and Prospect (2013-2025)
  1.4.3 Japan Status and Prospect (2013-2025)
  1.4.4 South Korea Status and Prospect (2013-2025)
  1.4.5 Taiwan Status and Prospect (2013-2025)
  1.4.6 India Status and Prospect (2013-2025)
  1.4.7 Southeast Asia Status and Prospect (2013-2025)
  1.4.8 Australia Status and Prospect (2013-2025)
1.5 Asia-Pacific Market Size (Value and Volume) of Therapeutic Nuclear Medicines (2013-2025)
  1.5.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Growth Rate (2013-2025)
  1.5.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2025)

2 ASIA-PACIFIC THERAPEUTIC NUCLEAR MEDICINES COMPETITION BY PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 Asia-Pacific Therapeutic Nuclear Medicines Market Competition by Players/Suppliers
  2.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Share by Players/Suppliers (2013-2018)
2.2 Asia-Pacific Therapeutic Nuclear Medicines (Volume and Value) by Type
  2.2.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Type (2013-2018)
  2.2.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Market Share by Type (2013-2018)
2.3 Asia-Pacific Therapeutic Nuclear Medicines (Volume) by Application
2.4 Asia-Pacific Therapeutic Nuclear Medicines (Volume and Value) by Region
  2.4.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Region (2013-2018)
  2.4.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Market Share by Region (2013-2018)

3 CHINA THERAPEUTIC NUCLEAR MEDICINES (VOLUME, VALUE AND SALES PRICE)

3.1 China Therapeutic Nuclear Medicines Sales and Value (2013-2018)
  3.1.1 China Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2013-2018)
  3.1.2 China Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
  3.1.3 China Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
3.2 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
3.3 China Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

4 JAPAN THERAPEUTIC NUCLEAR MEDICINES (VOLUME, VALUE AND SALES PRICE)

4.1 Japan Therapeutic Nuclear Medicines Sales and Value (2013-2018)
  4.1.1 Japan Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2013-2018)
  4.1.2 Japan Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
  4.1.3 Japan Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
4.2 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
4.3 Japan Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

5 SOUTH KOREA THERAPEUTIC NUCLEAR MEDICINES (VOLUME, VALUE AND SALES PRICE)

5.1 South Korea Therapeutic Nuclear Medicines Sales and Value (2013-2018)
  5.1.1 South Korea Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2013-2018)
  5.1.2 South Korea Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
  5.1.3 South Korea Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
5.2 South Korea Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
5.3 South Korea Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

6 TAIWAN THERAPEUTIC NUCLEAR MEDICINES (VOLUME, VALUE AND SALES PRICE)

6.1 Taiwan Therapeutic Nuclear Medicines Sales and Value (2013-2018)
  6.1.1 Taiwan Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2013-2018)
  6.1.2 Taiwan Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
  6.1.3 Taiwan Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
6.2 Taiwan Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
6.3 Taiwan Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

7 INDIA THERAPEUTIC NUCLEAR MEDICINES (VOLUME, VALUE AND SALES PRICE)

7.1 India Therapeutic Nuclear Medicines Sales and Value (2013-2018)
  7.1.1 India Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2013-2018)
  7.1.2 India Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
  7.1.3 India Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
7.2 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
7.3 India Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

8 SOUTHEAST ASIA THERAPEUTIC NUCLEAR MEDICINES (VOLUME, VALUE AND SALES PRICE)

8.1 Southeast Asia Therapeutic Nuclear Medicines Sales and Value (2013-2018)
  8.1.1 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2013-2018)
  8.1.2 Southeast Asia Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
  8.1.3 Southeast Asia Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
8.2 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
8.3 Southeast Asia Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

9 AUSTRALIA THERAPEUTIC NUCLEAR MEDICINES (VOLUME, VALUE AND SALES PRICE)

9.1 Australia Therapeutic Nuclear Medicines Sales and Value (2013-2018)
  9.1.1 Australia Therapeutic Nuclear Medicines Sales Volume and Growth Rate (2013-2018)
  9.1.2 Australia Therapeutic Nuclear Medicines Revenue and Growth Rate (2013-2018)
  9.1.3 Australia Therapeutic Nuclear Medicines Sales Price Trend (2013-2018)
9.2 Australia Therapeutic Nuclear Medicines Sales Volume and Market Share by Type
9.3 Australia Therapeutic Nuclear Medicines Sales Volume and Market Share by Application

10 ASIA-PACIFIC THERAPEUTIC NUCLEAR MEDICINES PLAYERS/SUPPLIERS PROFILES AND SALES DATA

10.1 Cardinal Health
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.1.2.1 Product A
    10.1.2.2 Product B
  10.1.3 Cardinal Health Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.1.4 Main Business/Business Overview
10.2 Mallinckrodt
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.2.2.1 Product A
    10.2.2.2 Product B
  10.2.3 Mallinckrodt Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.2.4 Main Business/Business Overview
10.3 GE Healthcare
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.3.2.1 Product A
    10.3.2.2 Product B
  10.3.3 GE Healthcare Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.3.4 Main Business/Business Overview
10.4 Lantheus Medical Imaging
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.4.2.1 Product A
    10.4.2.2 Product B
  10.4.3 Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.4.4 Main Business/Business Overview
10.5 Bayer
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.5.2.1 Product A
    10.5.2.2 Product B
  10.5.3 Bayer Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.5.4 Main Business/Business Overview
10.6 Bracco Imaging
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.6.2.1 Product A
    10.6.2.2 Product B
  10.6.3 Bracco Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.6.4 Main Business/Business Overview
10.7 Eczacibasi-Monrol Nuclear Products
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.7.2.1 Product A
    10.7.2.2 Product B
  10.7.3 Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.7.4 Main Business/Business Overview
10.8 Nordion
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.8.2.1 Product A
    10.8.2.2 Product B
  10.8.3 Nordion Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.8.4 Main Business/Business Overview
10.9 Advanced Accelerator Applications
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.9.2.1 Product A
    10.9.2.2 Product B
  10.9.3 Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.9.4 Main Business/Business Overview
10.10 IBA Molecular Imaging
  10.10.1 Company Basic Information, Manufacturing Base and Competitors
  10.10.2 Therapeutic Nuclear Medicines Product Category, Application and Specification
    10.10.2.1 Product A
    10.10.2.2 Product B
  10.10.3 IBA Molecular Imaging Therapeutic Nuclear Medicines Sales, Revenue, Price and Gross Margin (2013-2018)
  10.10.4 Main Business/Business Overview

11 THERAPEUTIC NUCLEAR MEDICINES MANUFACTURING COST ANALYSIS

11.1 Therapeutic Nuclear Medicines Key Raw Materials Analysis
  11.1.1 Key Raw Materials
  11.1.2 Price Trend of Key Raw Materials
  11.1.3 Key Suppliers of Raw Materials
  11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
  11.2.1 Raw Materials
  11.2.2 Labor Cost
  11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Therapeutic Nuclear Medicines

12 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

12.1 Therapeutic Nuclear Medicines Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2017
12.4 Downstream Buyers

13 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

13.1 Marketing Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
  13.2.1 Pricing Strategy
  13.2.2 Brand Strategy
  13.2.3 Target Client
13.3 Distributors/Traders List

14 MARKET EFFECT FACTORS ANALYSIS

14.1 Technology Progress/Risk
  14.1.1 Substitutes Threat
  14.1.2 Technology Progress in Related Industry
14.2 Consumer Needs/Customer Preference Change
14.3 Economic/Political Environmental Change

15 ASIA-PACIFIC THERAPEUTIC NUCLEAR MEDICINES MARKET FORECAST (2018-2025)

15.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume, Revenue and Price Forecast (2018-2025)
  15.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast (2018-2025)
  15.1.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast (2018-2025)
  15.1.3 Asia-Pacific Therapeutic Nuclear Medicines Price and Trend Forecast (2018-2025)
15.2 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Volume and Growth Rate Forecast by Region (2018-2025)
  15.2.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Growth Rate Forecast by Region (2018-2025)
  15.2.3 China Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.4 Japan Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.5 South Korea Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.6 Taiwan Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.7 India Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.8 Southeast Asia Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2018-2025)
  15.2.9 Australia Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate Forecast (2018-2025)
15.3 Asia-Pacific Therapeutic Nuclear Medicines Sales, Revenue and Price Forecast by Type (2018-2025)
  15.3.1 Asia-Pacific Therapeutic Nuclear Medicines Sales Forecast by Type (2018-2025)
  15.3.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue Forecast by Type (2018-2025)
  15.3.3 Asia-Pacific Therapeutic Nuclear Medicines Price Forecast by Type (2018-2025)
15.4 Asia-Pacific Therapeutic Nuclear Medicines Sales Forecast by Application (2018-2025)

16 RESEARCH FINDINGS AND CONCLUSION

17 APPENDIX

17.1 Methodology/Research Approach
  17.1.1 Research Programs/Design
  17.1.2 Market Size Estimation
  17.1.3 Market Breakdown and Data Triangulation
17.2 Data Source
  17.2.1 Secondary Sources
  17.2.2 Primary Sources
17.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Therapeutic Nuclear Medicines
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume Market Share by Type (Product Category) in 2017
Figure Beta Emitters Product Picture
Figure Alpha Emitters Product Picture
Figure Brachytherapy Products Product Picture
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales (K Units) by Application (2013-2025)
Figure Asia-Pacific Sales Market Share of Therapeutic Nuclear Medicines by Application in 2017
Figure Thyroid Examples
Table Key Downstream Customer in Thyroid
Figure Bone Metastasis Examples
Table Key Downstream Customer in Bone Metastasis
Figure Lymphoma Examples
Table Key Downstream Customer in Lymphoma
Figure Endocrine Tumors Examples
Table Key Downstream Customer in Endocrine Tumors
Figure Others Examples
Table Key Downstream Customer in Others
Figure Asia-Pacific Therapeutic Nuclear Medicines Market Size (Million USD) by Region (2013-2025)
Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure South Korea Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Taiwan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Australia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate (2013-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Market Major Players Product Sales Volume (K Units)(2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales (K Units) of Key Players/Suppliers (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure 2017 Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Players/Suppliers
Figure Asia-Pacific Therapeutic Nuclear Medicines Market Major Players Product Revenue (Million USD) 2013-2018
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 Asia-Pacific Therapeutic Nuclear Medicines Revenue Share by Players
Figure 2017 Asia-Pacific Therapeutic Nuclear Medicines Revenue Share by Players
Table Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Type (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Type (2013-2018)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Type (2013-2018)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Growth Rate by Type (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Type (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Type (2013-2018)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Growth Rate by Type (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (K Units) and Market Share by Region (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Share by Region (2013-2018)
Figure Sales Market Share of Therapeutic Nuclear Medicines by Region (2013-2018)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Region in 2017
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Market Share by Region (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Therapeutic Nuclear Medicines by Region (2013-2018)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share by Region in 2017
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (K Units) and Market Share by Application (2013-2018)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Share (%) by Application (2013-2018)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2013-2018)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Application (2013-2018)
Figure China Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
Table China Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
Table China Therapeutic Nuclear Medicines Sales Volume (K Units) by Applications (2013-2018)
Table China Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
Figure China Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
Figure Japan Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
Table Japan Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
Table Japan Therapeutic Nuclear Medicines Sales Volume (K Units) by Applications (2013-2018)
Table Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
Figure Japan Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
Figure South Korea Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure South Korea Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
Figure South Korea Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
Table South Korea Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
Table South Korea Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
Figure South Korea Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
Table South Korea Therapeutic Nuclear Medicines Sales Volume (K Units) by Applications (2013-2018)
Table South Korea Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
Figure South Korea Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
Figure Taiwan Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Taiwan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
Figure Taiwan Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
Table Taiwan Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
Table Taiwan Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
Figure Taiwan Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
Table Taiwan Therapeutic Nuclear Medicines Sales Volume (K Units) by Applications (2013-2018)
Table Taiwan Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
Figure Taiwan Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
Figure India Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
Table India Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
Table India Therapeutic Nuclear Medicines Sales Volume (K Units) by Application (2013-2018)
Table India Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
Figure India Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
Figure Southeast Asia Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume (K Units) by Applications (2013-2018)
Table Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
Figure Australia Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Australia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate (2013-2018)
Figure Australia Therapeutic Nuclear Medicines Sales Price (USD/Unit) Trend (2013-2018)
Table Australia Therapeutic Nuclear Medicines Sales Volume (K Units) by Type (2013-2018)
Table Australia Therapeutic Nuclear Medicines Sales Volume Market Share by Type (2013-2018)
Figure Australia Therapeutic Nuclear Medicines Sales Volume Market Share by Type in 2017
Table Australia Therapeutic Nuclear Medicines Sales Volume (K Units) by Applications (2013-2018)
Table Australia Therapeutic Nuclear Medicines Sales Volume Market Share by Application (2013-2018)
Figure Australia Therapeutic Nuclear Medicines Sales Volume Market Share by Application in 2017
Table Cardinal Health Therapeutic Nuclear Medicines Basic Information List
Table Cardinal Health Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Cardinal Health Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure Cardinal Health Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table Mallinckrodt Therapeutic Nuclear Medicines Basic Information List
Table Mallinckrodt Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mallinckrodt Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Mallinckrodt Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure Mallinckrodt Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table GE Healthcare Therapeutic Nuclear Medicines Basic Information List
Table GE Healthcare Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure GE Healthcare Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure GE Healthcare Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Basic Information List
Table Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure Lantheus Medical Imaging Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table Bayer Therapeutic Nuclear Medicines Basic Information List
Table Bayer Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bayer Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Bayer Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure Bayer Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table Bracco Imaging Therapeutic Nuclear Medicines Basic Information List
Table Bracco Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Bracco Imaging Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Bracco Imaging Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure Bracco Imaging Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Basic Information List
Table Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure Eczacibasi-Monrol Nuclear Products Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table Nordion Therapeutic Nuclear Medicines Basic Information List
Table Nordion Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Nordion Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Nordion Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure Nordion Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table Advanced Accelerator Applications Therapeutic Nuclear Medicines Basic Information List
Table Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure Advanced Accelerator Applications Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure Advanced Accelerator Applications Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Basic Information List
Table IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate (2013-2018)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Sales Market Share in Asia-Pacific (2013-2018)
Figure IBA Molecular Imaging Therapeutic Nuclear Medicines Revenue Market Share in Asia-Pacific (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price (USD/Unit) Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Therapeutic Nuclear Medicines
Figure Manufacturing Process Analysis of Therapeutic Nuclear Medicines
Figure Therapeutic Nuclear Medicines Industrial Chain Analysis
Table Raw Materials Sources of Therapeutic Nuclear Medicines Major Manufacturers in 2017
Table Major Buyers of Therapeutic Nuclear Medicines
Table Distributors/Traders List
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Price (USD/Unit) and Trend Forecast (2018-2025)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Volume (K Units) Forecast by Region (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Volume Market Share Forecast by Region in 2025
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Region (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share Forecast by Region (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share Forecast by Region in 2025
Figure China Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure China Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Japan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure South Korea Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure South Korea Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Taiwan Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Taiwan Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure India Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Australia Therapeutic Nuclear Medicines Sales (K Units) and Growth Rate Forecast (2018-2025)
Figure Australia Therapeutic Nuclear Medicines Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales (K Units) Forecast by Type (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue (Million USD) Forecast by Type (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share Forecast by Type (2018-2025)
Table Asia-Pacific Therapeutic Nuclear Medicines Price (USD/Unit) Forecast by Type (2018-2025)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales (K Units) Forecast by Application (2018-2025)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories